Liposomal formulation of a self lymphoma antigen induces potent protective antitumor immunity.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (25)
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.
1993 • 2,828 citations
Induction of Immune Responses in Patients with B-Cell Lymphoma against the Surface-Immunoglobulin Idiotype Expressed by Their Tumors
1992 • 551 citations
Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity.
1994 • 482 citations
Presentation of Exogenous Antigen with Class I Major Histocompatibility Complex Molecules
1990 • 338 citations
Myeloma Proteins as Tumor-Specific Transplantation Antigens
1972 • 325 citations
Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma
1993 • 314 citations
Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo
1994 • 300 citations
Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor
1995 • 269 citations
DNA immunization induces protective immunity against B–cell lymphoma
1996 • 252 citations
Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells
1991 • 250 citations
Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response.
1996 • 232 citations
Characterization of a carcinogen‐induced murine B lymphocyte cell line of C3H/eB origin
1977 • 169 citations
Idiotype vaccination against murine B cell lymphoma. Inhibition of tumor immunity by free idiotype protein.
1987 • 168 citations
Idiotype vaccination against murine B cell lymphoma. Humoral and cellular requirements for the full expression of antitumor immunity.
1990 • 144 citations
Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1.
1987 • 142 citations
In vivo cytotoxic T lymphocyte induction with soluble proteins administered in liposomes.
1992 • 133 citations
Antibody to a molecularly-defined antigen confined to a tumour cell surface
1975 • 128 citations
PROTECTIVE AND CELLULAR IMMUNE RESPONSES TO IDIOTYPIC DETERMINANTS ON CELLS FROM A SPONTANEOUS LYMPHOMA OF NZB/NZW F1 MICE
1974 • 75 citations
Induction of Secretion of IgM from Cells of the B Cell Line 38C-13 by Somatic Cell Hybridization
1979 • 70 citations
A Genetic Approach to Idiotypic Vaccination
1993 • 69 citations
Recognition of an immunoglobulin VH epitope by influenza virus-specific class I major histocompatibility complex-restricted cytolytic T lymphocytes.
1994 • 61 citations
Immunization with the Light Chain and the VL Domain of the Isologous Myeloma Protein 315 Inhibits Growth of Mouse Plasmacytoma MOPC315
1980 • 40 citations
Europium-labelled streptavidin as a highly sensitive universal label
1992 • 40 citations
Interleukin‐2 in liposomes: Increased intravenous potency and less pulmonary toxicity in the rat
1992 • 37 citations
Participation of the Humoral Immune System in the Myeloma-Specific Transplantation Resistance
1978 • 30 citations